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Cancer cells in poorly vascularized tumor regions need to adapt to an unfavorable metabolic
microenvironment. As distance from supplying blood vessels increases, oxygen and nutrient
concentrations decrease and cancer cells react by stopping cell cycle progression and becoming
dormant. As cytostatic drugs mainly target proliferating cells, cancer cell dormancy is considered
as a major resistance mechanism to this class of anti-cancer drugs. Therefore, substances that
target cancer cells in poorly vascularized tumor regions have the potential to enhance cytostatic-
based chemotherapy of solid tumors.
With three-dimensional growth conditions, multicellular tumor spheroids (MCTS) reproduce
several parameters of the tumor microenvironment, including oxygen and nutrient gradients as
well as the development of dormant tumor regions.
We here report the setup of a 3D cell culture compatible high-content screening system and
the identiﬁcation of nine substances from two commercially available drug libraries that
speciﬁcally target cells in inner MCTS core regions, while cells in outer MCTS regions or in 2D
cell culture remain unaffected. We elucidated the mode of action of the identiﬁed compounds as
inhibitors of the respiratory chain and show that induction of cell death in inner MCTS core
regions critically depends on extracellular glucose concentrations. Finally, combinational treat-
ment with cytostatics showed increased induction of cell death in MCTS. The data presented here
shows for the ﬁrst time a high-content based screening setup on 3D tumor spheroids for the
identiﬁcation of substances that speciﬁcally induce cell death in inner tumor spheroid corelsevier Inc.
heroid; mDSLM, monolithic digital light sheet based ﬂuorescence microscope; HCS, high content
com (P. Steigemann).
Open access under CC BY-NC-ND license.
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 3 ( 2 0 1 4 ) 1 3 1 – 1 4 3132regions. This validates the approach to use 3D cell culture screening systems to identify
substances that would not be detectable by 2D based screening in otherwise similar culture
conditions.
& 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
One of the main properties of cancer cells is sustained prolifera-
tive growth. Accordingly, the cell cycle is a major target for
chemotherapy. Cytostatic drugs show strong anti-cancer efﬁcacy
in conventional in vitro assays; however, ﬁndings from 2D cell
culture based experiments can only be partially translated to
experimental outcomes in vivo and resistance to chemotherapy is
still a frequent cause for treatment failure in patients with
advanced and inoperable cancer. Several factors confer resistance
to standard treatment regimens including, but not limited to,
pharmacokinetic properties, genetic heterogeneity, drug clear-
ance by cancer cells [1–4]. As commonly used cytostatics mainly
target proliferating cells, tumor cell dormancy could be a factor
for a limited response to these compounds [5,6].
Tumor cell dormancy is inﬂuenced by regional differences in
oxygen and nutrient supply within the neoplastic tissue, depend-
ing on the amount and quality of (neo-) vascularization (i.e. the
distance from supplying blood vessels). As tumor growth requires
high amounts of energy and nutrients, tumor cell proliferation is
therefore mainly restricted to regions adjacent to blood vessels
and human tumor tissue can show relatively low proliferative
indices in poorly perfused areas [3,5,7,8]. Cancer tissue can
therefore be subdivided, depending on vascularization, into
well-supplied, proliferating tumor cell regions in the vicinity of
blood vessels and mostly dormant cells in poorly vascularized
tumor regions.
Dormant cancer cells could potentially lead to disease relapse
after cytostatic-based chemotherapy. Therefore, targeting this
cell population could be of interest to enhance cytostatic-based
chemotherapy [6].
Despite the potential role of dormant cells in limiting the
effectiveness of cytostatic-based chemotherapy, few efforts have
been made to speciﬁcally target this tumor cell population
[6,9,10]. This could be due to the fact, at least in part, that there
is a lack of appropriate screening-compatible in vitro models that
are able to simulate the metabolic microenvironment in tumors.
Recently, 3D cancer cell culture models have gained interest, as
they have the potential to mimic the complex three dimensional
organization of tumor tissue in vivo. Similar to native tumor tissue,
cells cultured as multicellular tumor spheroids (MCTS) show strong
proliferation gradients that reﬂect distribution gradients of oxygen,
nutrients and energy, as well as the accumulation of metabolites
from outer to inner spheroid regions [3,4,11–13]. However, conven-
tional 3D-based methods are not able to identify localized pheno-
types in 3D models. Therefore we set up a high throughput, high-
content microscopy compatible 3D MCTS assay on 384-well micro-
titer plates to identify substances that speciﬁcally target dormant
cells in MCTS core regions. As a proof of principle, we screened two
small compound libraries and identiﬁed nine hits that speciﬁcally
target cells in inner tumor spheroid regions, while cells in outer
regions or cultured under 2D cell culture conditions remainunaffected. We identiﬁed all hits as being inhibitors of the respira-
tory chain and further characterized their mode of action in MCTS.
Finally, we showed additive effects in combination therapy with
selected compounds when combined with cytostatics in vitro.Materials and methods
Spheroid generation
Spheroid generation was carried out using a modiﬁed version of
the liquid overlay cultivation technique described previously [14].
For the generation of imaging-compatible 3D tumor spheroids,
10 ml of a heated 1.5% w/v agarose (in DMEM without phenol red
and fetal bovine serum (FBS)) solution was dispended by liquid
dispensers (Multidrop Combi, Thermo Scientiﬁc) into sterile
384-well clear bottom imaging plates. To prevent premature
gelation of the agarose suspension, the multidrop and dispensing
cassette was heated by infrared lamps. For tumor spheroid
seeding, a single cell suspension was seeded into agarose-coated
(1.5% w/v) 384-well clear bottom plates in 40 ml RPMI1640
containing 10% (v/v) FBS supplemented with 1% Penicillin/Strep-
tomycin (and 0.01 mg/ml insulin for T47D cells (Gibco)) using a
liquid dispenser. Cell lines seeding number was optimized to
obtain spheroids with an approximate diameter of 400 mm on day
4 and were seeded in following density: 2000 cells per well (c/w)
for T47D, 5000 c/w for DLD1, 2000 c/w for DU145, and 1000 c/w
for primary colon cancer cells. For schematic overview please see
Supplementary Fig. S2.
The plates were incubated under standard cell culture condi-
tions at 37 1C and 5% CO2 in humidiﬁed incubators for 4 days
to allow formation of reproducible spheroids of deﬁned size
and morphology. In general approximately 50% of all tested cell
lines are capable of spheroid formation in these conditions. As
described by others [15] spheroid formation can be facilitated by
addition of low percentage of reconstituted basement membrane
preparation if cells are not capable of forming compact spheroids
(e.g., BD Matrigel). Drugs (Enzo Life Sciences Screen-Wells FDA
Approved Drug library (640 compounds) and Screen-Wells ICCB
Known Bioactives library (480 compounds)) were added in 20 ml
culture medium for additional 3 days.
Prior to imaging, spheroids were stained for 24 h by adding
Hoechst 33342 (1 mg/ml, Life Technologies) as counterstain for all
nuclei and Sytox Green, as stain for dead cells (2 mM, Life
Technologies) at a ﬁnal dilution of 1:10,000 each.Image acquisition
One image per spheroid and wavelength, focused on the spheroid
center was captured by Molecular Devices Micro wideﬁeld system
with a 2 objective. Quantiﬁcation of inner core cell death was
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written image analysis routines. Brieﬂy, spheroid borders were
detected on Hoechst channel and masks were generated, scaled
down and transferred on to the Sytox Green channel to quantify
cell death in inner spheroid regions. All images were captured as
12-bit tiff ﬁles and no non-linear corrections have been applied.
3D image acquisition was done on a custom build mDSLM
microscopy system as described earlier [16]. Brieﬂy samples were
dehydrated in an ascending ethanol series (50%, 70%, 85%, and
99%) for 5 min each. Then spheroids were transferred to benzyl
alcohol/benzyl benzoate (1:1, v/v), transferred in a glass capillary
and imaged using 2.5 illumination objective and 10 detection
objective. 142 z-planes with 2.58 mm spacing were imaged for
T47D spheroid in movie 1, 137 z-planes were imaged for anti-
mycin A (100 nM) treated MCTS. 3D reconstruction and movie
generation was done with Imaris software (Bitplane).Cytotoxicity assay
For 2D toxicity assessment T47D cells were seeded at 2250 cells
per well (c/w) in 40 ml on 384-well plates and were allowed to
attach for 24 h. After 3 days drug incubation, cell viability was
determined. Hoechst (1 mg/ml) and Sytox Green (2 mM) were
used for staining at a ﬁnal concentration of 1:10,000. Cell death
index was calculated by counting all cells (as detected by Hoechst
staining) divided by the number of Sytox Green positive dead
cells.Cell titer glo assay
Viability for in vitro combination studies in MCTS was measured
with Cell Titer Glo Assay (Promega). To support reagent penetra-
tion, lysis and ATP recovery from MCTS an equal volume of
reagent was added to sample and shaken for 15 min at 450 rpm.
Luminescence readout was done after 30 min incubation at room
temperature.Immunohistochemistry
Prior to harvesting, spheroids were ﬁxed for 24 h in 4% PFA. Then
spheroids were transferred to 50 mL tubes (Falcon), washed twice
in ice-cold DPBS and equilibrated in 30% sucrose (w/v) DPBS
solution for 1 h. Then spheroids were transferred to cryomolds
and covered in Tissue-Tek OCT compound. After 30 min of
equilibration cryomolds were frozen by incubation in a mixture
of dry ice and 2-methylbutane (Sigma Aldrich). Prepared samples
were cut into 5 mm sections by cryostat, mounted on SuperFrost
Plus slides (Menzel-Glaser) and then rehydrated in DPBS
for 20 min. After 1 h in blocking and permeabilization solution
(1% BSA, 0.1%Triton, 0.1% TWEEN-20) the primary antibody
was incubated overnight at 4 1C. Incubation and staining with
Hypoxyprobe-1 kit (Hypoxyprobe-1, Chemicon), mouse monoclo-
nal IgG1 labeled with FITC and cell labeling with Click-iT EdU
imaging kit (Alexa Fluor 555 azide, Life Technologies) were done
according to the respective manufacturers instructions. After
staining, slides were mounted in Slowfade Gold (Life Technolo-
gies) and imaged on AxioInvert 500 (Carl Zeiss) with 10 air
objective and attached camera.T47D breast cancer cell harvesting and NMR spectroscopy
For the extraction of metabolites and sample preparation for 1H
NMR spectroscopy the protocol from [17] was adapted to T47D
breast cancer cells. In brief, cells were washed, methanol quenched
and transferred for subsequent extraction. Spectra of extracted
aqueous metabolite phase were acquired in 3 mm NMR tubes at
600.13 MHz and 300 K using a Bruker AVANCE III spectrometer
equipped with a TCI-Cryo-Probe and a sample jet system (Bruker
BioSpin). The residual water signal was suppressed by a 1D-NOESY
presaturation pulse sequence. Typically, a total of 512 transients
each of 64 k data points was acquired with an acquisition time of
2.65 s, an interpulse delay of 4 s, a spectral width of 20 ppm and a
pulse width of 8.2 ms at 5 dB (901). The free induction decay (FID)
was multiplied by a 0.3 Hz exponential line-broadening factor to
improve the signal-to-noise ratio prior to Fourier transformation.
Phase correction and referencing were performed using Topspin
2.1 (Bruker BioSpin). For the baseline correction ACD Software Suite
12 (ACD/Labs) was used. The TSP signal was set to 0.00 ppm.
NMR data analysis
Multivariate analysis of the integrated bucket data was performed
using SIMCA-P software (version 13.0, Umetrics AB) applying
pareto scaling. Unsupervised principal components analysis (PCA)
and supervised models (PLS-DA, OPLS-DA) were used to extract
the main drivers, or spectral regions of the spectra responsible for
group separation.
Metabolites were manually annotated and quantiﬁed with the
help of the Chenomx NMR Suite 7.5 (Chenomx Inc.). The meta-
bolite concentrations were expressed in (mM) using the inte-
grated TSP region (0.025 mM). The heatmap was built using the
same called function of GNU R 3.0.1. Data was logarithmized in
advance and clustered with hierarchical clustering using Eucli-
dean distance measure and complete linkage agglomeration.
Seahorse
Oxygen consumption rate (OCR) and extracellular acidiﬁcation
rate (ECAR) were measured with an XFe Extracellular Flux
Analyzer (Seahorse Bioscience) according to manufacturer's
instructions. In brief, cells were plated at 25,000 cells/well on
96-well multiplates (Custom Seahorse cell culture plates) in
standard cell culture medium. After 24 h media was exchanged
to non-buffered RPMI1640 containing 11 mM glucose and 2 mM
glutamine and equilibrated in a CO2-free incubator for 1 h. XF
assay consisted of sequential mix, pause and measurement steps,
allowing determination of OCR and ECAR every 10 min for up to
180 min. The concentrations used in this assay are given in
Supplementary Table 1.
Mesoscale AMPK activation
AMPK activation was determined by MSD (meso scale discovery)
assay for human duplex (phospho) alpha1-AMPK on threonine
172. Samples were collected following manufacturer's instruc-
tions and adjusted to same protein concentrations (30 mg/well).
Phosphorylated AMPK was normalized to total AMPK amount and
used as readout for AMPK activation.
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RNA was extracted using the 6100 NucleicPrepStation (Applied
Biosystems) according to manufacturer's instructions and quanti-
ﬁed on the 8-channel Nanodrop spectrophotometer (ND-8000,
Thermo Scientiﬁc). cDNA was produced using the GeneAmps
RNA PCR Kit (Life Technologies) and quantitative reverse tran-
scription PCR (RT-qPCR) was conducted using Applied Biosystems
TaqMans Gene Expression Assays before analysis on the 7900
PCR machine (Applied Biosystems). Relative mRNA levels were
calculated to the geometric mean of reference genes ACTB
(encoding Beta-actin) and RPL13A (encoding 60S ribosomal
protein L13a). Full gene names: ACYL (ATP citrate lyase), GLUT1
(solute carrier family 2 (facilitated glucose transporter), member
1), ANGPTL4 (angiopoietin-like 4), BNIP3 (BCL2/adenovirus E1B
19 kDa interacting protein 3), CA9 (carbonic anhydrase IX), VEGFA
(vascular endothelial growth factor A).
Statistical analysis and hit evaluation
One-way ANOVA tests for combination therapy experiments were
done using Prism software (GraphPad). Signiﬁcance of differences
between multiple groups was compared using a Bonferroni
posttest analysis. RT-qPCR gene expression levels and AMPK
activation levels were compared by multiple t-test using Prism
software (two-tailed t-test with Welch's correction).
Normalization, quality control, hit list generation and ﬁtting
curves for AC50 determination of identiﬁed hit compounds were
done with Genedata Screeners for high-content screening and
Genedata Condoseo modules (Genedata AG).Results
With three-dimensional growth conditions, multicellular tumor
spheroids (MCTS) mimic several parameters of the tumor micro-
environment in vivo. Based on their ability to effectively form
compact MCTS from a single cell suspension within 4 days (Movie
1—formation of a T47D MCTS from a single cell suspension, Fig. 1A
and Movie 2—illustration of a compact T47D MCTS after 4 days
incubation), we chose the T47D human breast cancer cell line as
an initial model system.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.yexcr.2014.01.017.
Cells in inner MCTS core regions experience similar conditions
as cancer cells in poorly vascularized tumor regions. In both
situations, concentration gradients of oxygen and nutrients, as
well as the accumulation of metabolites contribute to the forma-
tion of an unfavorable microenvironment. Indeed, MCTS slices
stained with anti-pimonidazole antibody, a marker for hypoxia,
showed strong hypoxia (o10 mmHg oxygen tension) deep inside
the MCTS (Supplementary Fig. S1). Accordingly, as compared to
the same cells cultured in 2D cell culture in otherwise identical
culture conditions, T47D spheroids showed up-regulation of
hypoxia- and low nutrition responsive genes (Fig. 1B).
Proliferation in tumor tissue occurs mainly in well-nourished
regions adjacent to supplying blood vessels reﬂecting the need for
high amounts of nutrients and energy for proliferation while cells
in nutrient deprived and hypoxic tumor regions remain mostly
dormant [3,6,7]. Similarly, proliferation in T47D spheroids can bedetected mainly in outer MCTS layers, while inner MCTS core
regions remain dormant (Fig. 1C).
As inner MCTS cells do not proliferate, we tested their response
to cytostatic therapy. Thus, we incubated T47D MCTS for 3 days
either with cisplatin or paclitaxel, two routinely used chemother-
apeutic agents. Similar to their toxic effect in 2D cell culture (data
not shown) these compounds induced widespread cell death in
T47D MCTS after 3 days of incubation (Fig. 1D). However, cell
death only occurred in outer spheroid regions, as a viable MCTS
core could be isolated after recovery from cytostatic treatment
and removal of the dead cell layer. In contrast, treatment with
staurosporine, a general cytotoxic agent, led to complete dissolu-
tion of the tumor spheroid and widespread cell death (Fig. 1D and
E). Therefore we conclude that dormant inner MCTS cells can
resist cisplatin and paclitaxel therapy.
For the generation of high numbers of reproducible 384-well
agarose-coated spheroid-containing plates for screening pur-
poses, we adapted the setup reported by Friedrich et al. [14] for
automated microscopy by using sterile clear bottom microtiter
plates and heated automatic liquid dispensers (see Material and
methods and Supplementary Fig. S2) for plate production.
This setup resulted in the generation of highly uniform and
reproducible spheroids with one spheroid per well (n¼1536
spheroids on four 384-well plates, standard deviation of total
spheroid area þ/7.5%).
To visualize spheroids and dead cells for high-content analysis,
ﬂuorescent dyes with sufﬁcient penetration in MCTS were used.
Images from the Hoechst 33342 channel were used to automati-
cally identify the total spheroid area and generate a mask, which
was then used as the region for intensity measurement in the
Sytox Green channel (visualizing cell death). Cell death in total
spheroids as well as in inner and outer spheroid regions was
measured and hits were characterized by a higher ratio of cell
death induced in inner tumor spheroid regions as compared to
outer regions (see Fig. 2A). Using this setup with one image per
wavelength taken at the center of the spheroid, we screened two
commercially available drug libraries (Enzo Life Sciences Screen-
Well FDA Approved Drug library (640 compounds) and Screen-
Well ICCB Known Bioactives library (480 compounds)), which
comprise a total of 1120 (n¼3 replicas) compounds (for setup and
high-content screening procedures, see Material and methods
and Fig. 2A) in one week. Given an average imaging time of
20 min per plate on an automated imaging system and two runs
per week this assay would be able to yield a minimum through-
put of 40,000 compounds per week in a high-throughput setup.
With a threshold of 430% intensity of the staurosporine
general cytotoxicity control (cell death measured by Sytox Green
staining intensity, median of 3 replicas), 44 compounds could be
identiﬁed that induce cell death in 3D tumor spheroids (black line
parallel to the X-axis in Supplementary Fig. S3A). For the
identiﬁcation of compounds that speciﬁcally induce cell death
in inner MCTS regions, we generated masks to measure Sytox
Green intensity (cell death) in inner core and outer ring regions of
the MCTS (see Fig. 2A for illustration) and calculated the ratio of
the intensity in inner core region versus intensity in the outer
layer. Compounds were characterized as hits if the intensity in the
Sytox Green channel (cell death) was at least 5 stronger in
inner core as compared to the outer MCTS region (see Fig. 2A for
illustration and black line parallel to the Y-axis in Supplementary
Fig. S3A). Nine hits that speciﬁcally led to cell death in inner MCTS
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Fig. 1 – Multicellular tumor spheroids (MCTS) mimic several parameters of the tumor microenvironment. (A) T47D breast cancer
MCTS: 2D projection of a 3D image stack of 142 z-planes with 2.58 lm spacing showing the organization of T47D spheroids. Cell
nuclei are stained with Hoechst (red) and dead cells are labeled with Sytox green (green). Scale bar, 100 lm. Please see also Movie 1.
(B) RT-qPCR shows up-regulation of hypoxia- and low nutrition responsive genes in MCTS compared to standard 2D cell culture
conditions. Geometric mean of reference genes ACTB and RPLP13A were used for normalization of all RT-qPCR results. Bars show
average of 3 biological replicates (þSD), nnpo0.01. For full gene names see material and methods. (C) Cryosections of an untreated
spheroid cultured for 5 days, stained with Hoechst (blue) and incubated 18 h with EdU probe (red). EdU, as a thymidine analog, is
incorporated into DNA in S-phase and indicates proliferating cells. Mainly outer cell layers of the MCTS show EdU incorporation
(see histogram of EdU signal in MCTS cross section). Scale bar, 100 lm. (D) Cytostatics, paclitaxel (100 nM) and cisplatin (100 lM),
mainly affect the outer proliferative layer in MCTS, which could be removed after 3 days treatment and 3 days of recovery by
pipetting. An inner cytostatic-resistant viable core could be isolated (arrows). The staurosporine (10 lM) cytotoxic control leads to
complete disruption of the MCTS. Scale bar, 100 lm. (E) Sytox green staining shows that isolated cytostatic-resistant cores (see D)
are viable. Scale bar, 100 lm.
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Fig. S3C).
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identiﬁed (Fig. 2B and Fig. S4). The Hitlist is provided in Table 1
and a 3D reconstruction of a treated MCTS in Movie 3 shows that
the MCTS inner core death phenotype can indeed speciﬁcally be
observed in the inner MCTS core region, while the outer cell layerremains unstained. All of the nine identiﬁed compounds show a
similar phenotype and did not induce cell death in 2D cell culture
at similar culture conditions (Fig. 2C and Supplementary Fig. S3C).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.yexcr.2014.01.017.
Table 1 – Identiﬁed hits that induce cell death in MCTS core regions and hit expansion with respiratory chain inhibitors with
respective AC50 (inner core death) values.
Compound name Library AC50 (3D) Proposed mode of action
Primary hits
AG-879 KBA 20 mM
Diphenyleindonium KBA 62 nM
MBCQ KBA 8 mM
Miconazole FDA 22 mM
Nefazodone FDA 15 mM
Oligomycin A KBA 3 nM Complex V inhibition
Pimozide FDA/KBA 11 mM
QNZ KBA 1 nM
Valinomycin KBA 3 nM Uncoupler
Hit expansion
Antimycin A 20 nM Complex III
Atpenin A5 o50 mM Complex II
Berberine 17 mM
Dinitrophenol 24 mM Uncoupler
FCCP 6 mM Uncoupler
Metformin 5 mM
Pentamidine 30 mM
Phenformin 142 mM
Rotenone 7 nM Complex I
Tyrphostin 9 1 mM
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identiﬁed hits exist. In a drug interaction matrix setup we tested
whether the combination of two compounds would lead to an
additive effect on MCTS compared to the single compounds. However,
all different combination treatments showed similar phenotypes as
the single compound treatment (Supplementary Fig. S4).
Two of the hit compounds, oligomycin A and valinomycin, are
well-known inhibitors of the respiratory chain (Complex V
inhibitor and ionophore, respectively [18]). Therefore we tested
all hits for their effect on cellular respiration by direct measurement
of alterations in oxygen consumption and lactate generation using
electro-optical detection based XFe extracellular ﬂux analyzer on 2D
cell cultures (see Material and methods). We found that all hits
affected oxygen consumption or lactate production and therefore
can be categorized as respiratory chain inhibitors (Fig. 3A and B).
Supporting this ﬁnding, all compounds altered the metabolic
ﬁngerprint of MCTS in a similar manner as measured by NMR
based spectroscopy and cluster together with known respiratory
chain inhibitors (see heatmap, Fig. 3C).
In a next step, we investigated the effect of compounds that are
known to act speciﬁcally on certain components of the respiratory
chain (Complex I, II, III, ATP synthase, see Table 1). All these
compounds led to similar phenotypes with cell death induction
in inner core regions of MCTS (Table 1 hit expansion and
Supplementary Fig. S4) and show no or only weak effects in 2D
cell culture (Supplementary Fig. S3C). Taken together, we con-
clude that all identiﬁed compounds affect cellular respiration and
that inhibition of the respiratory chain leads to cell death
speciﬁcally in core regions of MCTS.
Additionally, MCTS core death after respiratory chain inhibition
could also be induced on MCTS from different cancer cell lines
(e.g., colorectal adenocarcinoma DLD-1 cell line, epithelial prostate
cancer cell line DU145) and spheroids generated from primary
colon cancer biopsies (colon cancer liver metastasis-derivedprimary cell line) (Fig. 4A). These results show that oxidative
phosphorylation is required for cell survival in dormant MCTS core
regions of tumor spheroids derived from various tumor cell lines.
Inhibition of the respiratory chain leads to cellular energy stress
which is sensed by AMP-activated protein kinase (AMPK). AMPK
is activated by high AMP/ATP ratios and serves to reprogram the
cellular metabolism to resist low energy conditions by enhancing
catabolic pathways that generate ATP and reduction of ATP
consuming processes [19,20].
Indeed, inhibiting the respiratory chain with different inhibitors
(Antimycin A—Complex III, Metformin—Complex I, Rotenone—
Complex I, Nefazodone) induced AMPK activation in MCTS
(Fig. 4B). However, AMPK activation alone is not sufﬁcient to
induce cell death in inner tumor spheroid core regions as addition
of AMPK activators AICAR, PT-1 or Salicylate did not result in
MCTS core death (Supplementary Fig. S5A).
MCTS inner tumor spheroid cell death is preceded by caspase
activation as visualized by caspase 3/7 sensitive live cell staining
(see Movie 4 for caspase activation in inner core regions and also
Movie 5 showing a time delayed onset of cell death after
activation of caspases, quantiﬁcation is provided in Fig. 4C).
Additionally, the pan-caspase inhibitor Z-VAD-FMK leads to a
partial rescue of the phenotype induced by blocking the respira-
tory chain (Fig. 4D).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.yexcr.2014.01.017.
Taken together we conclude that inhibition of the respiratory
chain leads to AMPK activation and to induction of apoptosis in
MCTS core regions.
Two main energy producing pathways supply tumor cells with
ATP: oxidative phosphorylation and glycolysis. Therefore, we
speculated that outer MCTS cells (or cells cultured in 2D), with
direct access to glucose from the surrounding medium, could
switch to energy production by glycolysis and therefore prevent
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Fig. 3 – Identiﬁed compounds that induce cell death in MCTS core regions act as respiratory chain inhibitors. (A and B) Strong to
moderate decrease of oxygen consumption rate of T47D cells incubated with denoted hit compounds (inhibitor control¼complex I
inhibitor rotenone, 1 lM). For concentrations used please see Supplementary Table S1. Graph shows average of 3 replicates. Error
bars indicate þSEM. (C) Driver metabolites were measured by NMR spectroscopy and annotated, quantiﬁed and clustered with
hierarchical clustering using Euclidean distance measure and complete linkage agglomeration. Heatmap clustering reveals close
clustering of identiﬁed hits with known respiratory chain inhibitors (Valinomycin and oligomycin A). Scale, log(2) fold-change. For
concentrations used please see Supplementary Table S1.
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levels [21] would experience stronger energy stress and become
sensitive to the inhibition of the respiratory chain. Indeed, varying
glucose levels in the surrounding media directly inﬂuenced the
severity of the phenotype of respiratory chain inhibition. High
glucose concentrations prevent cell death in inner MCTS core
regions in response to inhibitors of the respiratory chain while
lowering glucose levels broadened the region and intensity of cell
death in MCTS (Fig. 5A), leading to cell death in the entire MCTS in
glucose-free conditions. Accordingly, co-addition of cytochalasin B
or 2-Deoxy-D-glucose (2-DG), inhibitors of cellular glucose uptake
or glycolysis, respectively, also lead to cell death in the entire MCTS,while solely inhibiting glucose transport or incubation in glucose-
free media does not induce cell death in MCTS (Fig. 5B). Therefore,
we conclude that the amount of available glucose in the extra-
cellular environment is a major determinant for sensitivity of MCTS
cells against inhibitors of the respiratory chain.
Respiratory chain inhibitors target dormant cells in poorly supplied
dormant MCTS core regions. Therefore, a combinationwith cytostatics
that additionally target the proliferative cell layer could have an
additive effect on MCTS cell death. To target proliferating cells, we
treated DLD1 and T47D tumor spheroids for 3 days with paclitaxel or
cisplatin and subsequently added metformin or antimycin A for
another 3 days to additionally target the dormant cell population in
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on MCTS overall cell death (Figs. 6A and B).Discussion
Cytostatic-based chemotherapy is a commonly used therapeutic
regimen for cancer treatment. However, cytostatics mainly targetproliferating cancer and are less effective against dormant cells
which could be a possible cause for only partial remission and
relapse of tumors after therapy [5,22,23]. Therefore, a therapeutic
option to target dormant tumor regions could support cancer
therapy.
3D multicellular tumor spheroids (MCTS) reproduce several
parameters of tumors in situ. By integrating automated liquid
handling systems for plate production, spheroid seeding,
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well and staining procedures, we here present a 384-well
microtiter plate based workﬂow for high-throughput high-
content based screening on 3D cell culture. High-content
analysis allows assessment of cell death with spatial resolution
and the identiﬁcation of substances that speciﬁcally induce
localized cell death inside the MCTS. As a proof of principle, we
screened two commercially available compound libraries, and
identiﬁed several substances that speciﬁcally lead to cell death
in dormant MCTS regions.
Our results indicate that all identiﬁed compounds act by a
similar mode of action and direct measurements of oxygen
consumption show that all identiﬁed substances interfere with
the proper function of the respiratory chain—either by acting as
inhibitors or uncouplers of the respiratory chain. Interestingly, for
induction of cell death in inner MCTS core regions the exact target
in the respiratory chain seems to be irrelevant, as complex I
inhibitors induce similar phenotypes as complex III/V inhibitors
or uncouplers of the respiratory chain.Given that cancer cells are predominantly glycolytic (Warburg
effect) and the observation that the targeted cells are located in
tumor areas with lower oxygen supply, the identiﬁcation of
respiratory chain inhibitors to selectively target cells in MCTS
core regions was rather surprising. However, MCTS slices stained
with pimonidazole, a marker for hypoxia, (Supplementary Fig. S1)
shows that the targeted dormant cells are not hypoxic but rather
are located in regions of intermediate oxygen supply, with anoxia
only in the innermost spheroid regions. Accordingly, inhibitors of
the respiratory chain had no additional effect when cultivated
under hypoxic (1% O2) conditions (data not shown). Similar
distributions can also be observed in tumor models, in which
proliferation occurs in the regions adjacent to the supplying blood
vessels, followed by dormant intermediate oxygenated regions
not yet stained positive for pimonidazole [3,6,7]. Therefore, we
conclude that the identiﬁed compounds lead to cell death in
regions of MCTS, in which respiration is still possible and required
for cell survival.
Cells in MCTS core regions strongly depend on respiration for
survival—possibly because of low levels of glucose that do not
allow glycolysis to provide sufﬁcient ATP. Accordingly, supple-
mentation of high glucose concentrations in the medium rescues
and lowering glucose levels strengthens the phenotype induced
by inhibition of the respiratory chain. This and complete spheroid
cell death after co-treatment with either an inhibitor of glucose
uptake (Cytochalasin B) or glycolysis (2-Deoxyglucose) indicates
that the level of glucose supply is one of the major determinants
of sensitivity of dormant cells to respiratory chain inhibition.
As growth media supplements and culture conditions have the
potential to strongly inﬂuence the phenotype and therefore
screening outcome, these ﬁndings identiﬁes media composition
(e.g., glucose concentration) and culture conditions (e.g., oxygen
levels) as important factors that may further need to be adjusted.
Even though 3D tissue culture better reﬂects the situation in the
tumor than 2D cell culture these models still remain artiﬁcial.
Medium composition and culture conditions need to closely
reﬂect the in vivo-situation to support the identiﬁcation of hits
with higher possibility to translate in vitro results to an effect
in vivo.
Based on the observation that respiratory chain inhibitors induce
cell death in dormant MCTS regions but do not affect the
proliferative layer, we expected weak efﬁciency in single therapy
and additive effects when combined with cytostatics that addi-
tionally target the proliferative layer. The results presented here
show increased induction of cell death in MCTS when respiratory
chain inhibitors are combined with cytostatics in vitro (Fig. 6A). In
summary, our data suggest that targeting cytostatic-resistant
tumor cells in dormant tumor regions with respiratory chain
inhibitors could be a therapeutic option that could enhance the
effectiveness of cytostatic-based chemotherapy.
However, a major question regarding these results is, if the
mechanisms identiﬁed here can be translated into anti-tumor
activity in vivo. Indeed, several complex I inhibitors show anti-
tumor activity in vivo, especially in combination with cytostatics
[24–26]. In vitro the effect induced by inhibitors of the respiratory
chain is dependent on extracellular levels of glucose. Interestingly,
metformin is in use as an anti-diabetic drug. Therefore the
reported cancer-protective effect [27] of metformin could be
induced by a combination of both, inhibition of complex I and
additionally lowering blood glucose levels.
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Fig. 6 – Combination therapy with cytostatics increases efﬁciency of respiratory chain inhibitors. (A) In vitro combination therapy
on T47D breast cancer spheroids. Combination of paclitaxel (100 nM) or cisplatin (100 lM) with either metformin (10 mM) or
antimycin A (100 nM) signiﬁcantly increases overall cell death in MCTS model. Bar shows average of 416 replicaþSD. (B) In vitro
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E X P E R I M E N T A L C E L L R E S E A R C H 3 2 3 ( 2 0 1 4 ) 1 3 1 – 1 4 3142Given that oxidative phosphorylation is the main energy source for
most eukaryotic cells, inhibition of the respiratory chain is considered
to be rather toxic on the whole organism level. However, we
identiﬁed FDA approved compounds which are used in the clinic
but act as respiratory chain inhibitors (e.g., miconazole, pimozide,
metformin). Interestingly, these compounds show either only mild
effect on cellular respiration (limited effectiveness in reducing oxygen
consumption in the seahorse assay) (pimozide, miconazole) or slow
kinetics (metformin) but induce a similar phenotype in MCTS as more
effective inhibitors (Supplementary Fig. S5B).
Thus, already partial inhibition of the respiratory chain could be
sufﬁcient for anti-cancer activity in vitro.Conclusion
In conclusion we show here that 3D high-content screening
enables the identiﬁcation of compounds that speciﬁcally target
cells in inner tumor spheroid core regions and that would not be
identiﬁed in 2D based screening approaches in otherwise similar
culture conditions. We show that a class of hits that induce cell
death speciﬁcally in inner tumor spheroid core regions consist of
inhibitors of the respiratory chain and that their phenotype
critically depends on extracellular glucose concentrations. These
ﬁndings could facilitate the establishment of secondary assays in
more extensive screening campaigns for early hit classiﬁcation
and identiﬁcation of non-respiratory chain hit classes with similar
phenotypes in the hit list. Furthermore we show that media
composition and culture conditions inﬂuence the phenotype and
should be carefully considered while setting up a 3D tumor
spheroid-based screening campaign.Conﬂict of interests
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